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A mutation in human DFNA5 is associated with autosomal dominant nonsyndromic hearing impairment. The function of DFNA5 protein
remains unknown and no experimental model has been described so far. Here we describe fission yeast Schizosaccharomyces pombe as a
model organism for studying the function of heterologously expressed DFNA5. We have expressed wild-type as well as mutant DFNA5
alleles under control of regulatable nmt1 promoter. Yeast cells tolerated expression of wild-type DFNA5, while expression of the mutant
DFNA5 allele, which is responsible for nonsyndromic autosomal dominant hearing impairment, led to cell cycle arrest. We identified new rat
and horse DFNA5 homologues and we describe a domain of homology shared between DFNA5 and the Mcm10 family of DNA replication
proteins. Genetic interactions between heterologously expressed DFNA5 and a fission yeast cdc23 (mcm10) mutant support a possible link
between DFNA5 and Mcm10 proteins.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Cell cycle; MCM10; Schizosaccharomyces pombe; Hearing impairment; DFNA5; Yeast1. Introduction
Hearing impairment is the most frequent sensory hand-
icap. Most of the childhood to early adulthood onset forms
of nonsyndromic hereditary hearing impairment exhibit an
autosomal dominant inheritance pattern and are indicated by
DFNA. To date, more than 90 chromosomal loci for non-
syndromic hearing impairment have been mapped to the
human genome (Hereditary Hearing Loss Homepage, Van
Camp and Smith, World Wide Web URL: http://www.uia.
ac.be/dnalab/hhh).
Human DFNA5 (ICERE-1) is one of the genes associated
with nonsyndromic autosomal dominant hearing impair-
ment. An insertion/deletion mutation in intron 7 of this gene
causes skipping of exon 8, resulting in premature termination0925-4439/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
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2 Present address: NIH, NIAID, LAD, Rockville, MD, USA.of the open reading frame [1]. In addition to its relevance to
hearing impairment, the expression pattern of human
DFNA5 indicated that this gene might participate in the
tumor biology of breast and skin cancers [2,3]. The physi-
ological function of the DFNA5 protein remains unknown
and computational analysis did not give any information on
the protein function [1]. In addition, no significant homology
with any other protein could be detected. Here we report that
DFNA5 shares sequence similarity with the Mcm10 family
of DNA replication proteins.
The Mcm10 (dna43) gene was first identified in yeast
Saccharomyces cerevisiae in two genetic screens for genes
required for chromosomal DNA replication and mini-chro-
mosome maintenance [4,5]. Mcm10 is required for efficient
initiation of DNA replication. Mcm10 may also be required
for the elongation step of DNA replication [6]. Recent
observations showed that Mcm10 performs its function after
prereplicative complex assembly and is required for loading
of Cdc45 onto chromatin [7] (J. Gregan and S.E. Kearsey,
unpublished data). All known members of the Mcm10
family share a conserved zinc-finger-like motif, referred to
as the CCCH domain [8], which is essential for the Mcm10ed.
Fig. 1. DFNA5 and Mcm10 proteins share a domain of homology. Multiple alignment of the Mcm10-CCCH domains of human (Swiss-Prot: Q9H3P9),
Xenopus laevis (Swiss-Prot: Q9DEX0), Drosophila melanogaster (GenBank: NP_610097), Caenorhabditis elegans (Swiss-Prot: Q9U2C2), Anopheles
gambiae (GenBank: EAA10332), Arabidopsis thaliana (GenBank: NP_179694), Schizosaccharomyces pombe (Swiss-Prot: O42709) and Saccharomyces
cerevisiae (Swiss-Prot: P32354) and of DFNA5 proteins from human (Swiss-Prot: O60443), mouse (Swiss-Prot: Q9Z2D3), horse (GenBank: AY194290) and
rat (GenBank: AY194291) aligned using CLUSTALW [22]. Identical residues are indicated by an asterisk, strong and weak conservations based on CLUSTAL
Ware indicated by a double dot and single dot respectively. The first and the last aligned residues in each of the sequences are designated on the right. The 90%
consensus shown below the alignment was calculated using Consensus (http://www.bork.embl-heidelberg.de:8080/Alignment/consensus.html) and the
following amino acid groupings were used: hydrophobic (h; A,C,F,G,H,I,K,L,M,R,T,V,W,Y), small (s; A,C,D,G,N,P,S,T,V), turnlike (t;
A,C,D,E,G,H,K,N,Q,R,S,T), polar (p; C,D,E,H,K,N,Q,R,S,T), charged (c; D,E,H,K,R).
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conserved cysteine residues resembling a zinc-finger motif
as well as conserved adjacent glycine and arginine residues
(Fig. 1).2. Materials and methods
2.1. Fission yeast methods
Media, growth conditions and genetic methods were as
described by Moreno et al. [11]. Thiamine was used at 5 Ag/
ml to repress the nmt1 promoter.
Flow cytometry analysis and microscopy were as de-
scribed in Ref. [12].
2.2. Plasmid constructs
2.2.1. Horse and rat homologues of DFNA5
A horse skin library in E ZAP Express [13] and a rat brain
library in E TriplEx (Clontech) were plated using standard
techniques. A 1500-bp mouse DFNA5 hybridization probe
was PCR-generated using primers 5V-GTTGATGCTGGAG-
GAGACC-3V and 5V-GTCTTGACCTGTAGCATGTCC-3V
and the previously cloned mouse Dfna5h as template [1].
The probe was purified with the QIAquick Gel Extraction
Kit (Qiagen). Membranes resulting from plaque lifting were
hybridized with the 32P-labelled probe using standard tech-
niques. Positive clones were rescreened to purity and phag-
emid was excised according to the manufacturer’s
guidelines. Inserts were sequenced using the Big-Dye Dye-
Terminator Cycle Sequencing Kit (ABI). Fragments were
separated on an ABI 3100 automated DNA sequencer (ABI).
After isolation of the partial rat cDNA, a rat-specific
probe was generated using PCR primers 5V-GGAGCTTCC-GTTCCTTTGC-3V and 5V-CAGCAGTGTTGCTGGTGT-
GC-3V. In addition, 5V-RACE experiments were performed
on the rat library using a rat DFNA5-specific primer 5V-
CCCAGCATTGTACAGCATGTCCAAAGG-3V and a Tri-
plEx vector primer 5V-CTCGGGAAGCGCGCCATTGTG-
TTGG-3V.
2.2.2. Cloning of human full-length and mutant DFNA5
To obtain a human full-length DFNA5 clone, a PCR re-
action was performed on Human Leukocyte Marathon-
Ready cDNA (Clontech) using the Advantage cDNA PCR
kit (Clontech) and the following primers: 5V-CCG-
ACATCTCCCGGATAATCTGG-3Vand 5V-GGTCAACTTT-
TAACGTGCATATGACC-3V. The PCR reaction consisted
of 35 cycles of 30-s denaturation at 94 jC and 4-min
extension at 68 jC. The PCR product was cloned into the
pT-Adv vector using the AdvanTAge PCR cloning kit
(Clontech).
To obtain a human mutant DFNA5 clone, total RNA was
isolated from EBV-transformed lymphoblastoid cell lines
derived from DFNA5 patients [1] using Trizol (Life Tech-
nologies). cDNAwas prepared using random hexamers from
the SuperScript Preamplification System (Life Technolo-
gies). A similar PCR reaction as described above was
performed. The resulting PCR fragments were cloned into
the pCR4-TOPO vector using the TOPO TA Cloning kit
(Invitrogen), and colonies that contained mutant DFNA5
were selected.
Both the human full-length and the mutant DFNA5
clones were completely bidirectionally sequenced in order
to exclude the introduction of cloning errors.
Mouse Dfna5h was PCR amplified from the pBluescript-
Dfna5h using oligonucleotide primers 5VXhoImouseDFNA5
(ATATCTCGAGATGTTTGCCAAAGCAACTC) and
3VSmaImouseDFNA5 (ATATCCCGGGCTAGTCTTGACC-
J. Gregan et al. / Biochimica et BiophyTGTAG) and cloned into XhoI and SmaI sites of the plasmid
pREP3x, resulting in pREP3x-mDFNA5.
Human DFNA5 was excised from the plasmid pT-Adv-
hDFNA5 by BamHI and SmaI and cloned into BamHI and
SmaI sites of the plasmid pREP3x, resulting in pREP3x-
hDFNA5. Mutant DFNA5 was excised from the plasmid
pCR4-hDFNA5mut by EcoRI and cloned into the EcoRI site
of the plasmid pT-Adv-hDFNA5, replacing the wild-type
DFNA5 allele and resulting in pT-Adv-hDFNA5mut plas-
mid. Mutant DFNA5 was excised from the plasmid pT-Adv-
hDFNA5mut by BamHI and HincII and cloned into the
BamHI and SmaI sites of the plasmid pREP3x, resulting
in pREP3x-hDFNA5mut plasmid. All constructs were veri-
fied by sequencing.Fig. 2. Multiple alignment of DFNA5 proteins. DFNA5 homologues from hum
AY194290) and partial sequence of the rat (GenBank: AY194291) were aligned usi
similar amino acid residues are in gray shades.2.3. Yeast strains
Degron-cdc23-M36 strain P1146 (cdc23-M36-td) was
constructed by BglII linearization of the plasmid
pSMRG2+ degron + cdc23 (J. Gregan and S.E. Kearsey,
unpublished data) and integration at the cdc23 locus of
the Schizosaccharomyces pombe strain P155 (cdc23-M36
h  ), which contained cdc23-M36 temperature-sensitive
allele. A similar strategy was used to construct degron-
cdc23-IE2 s t ra in P1145 (cdc23-IE2- td ) , where
pSMRG2+ degron + cdc23 plasmid was integrated at the
cdc23 locus of the S. pombe strain P893 (cdc23-IE2 leu1-32
h ), which contained the cdc23-IE2 temperature-sensitive
allele.
sica Acta 1638 (2003) 179–186 181an (Swiss-Prot: O60443), mouse (Swiss-Prot: Q9Z2D3), horse (GenBank:
ng CLUSTALW [22]. Identical amino acid residues are shaded in black and
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wild-type S. pombe strain P138 (ade6-M210 leu1-32 ura4-
D18 h ).
2.4. Reverse transcription-polymerase chain reaction (RT-
PCR) assay
RT-PCR were performed with total cellular RNA, avian
myeloblastosis virus reverse transcriptase and Tfl DNA
polymerase (Promega) according to the manufacturer’s
protocol.
Two oligonucleotide primers, DFNA5 5V(atgtttgccaaag-
caaccagg) and DFNA5 3V(tcagagatcacacacttctgc), were used
to amplify a 515-bp RT-PCR product corresponding to the
human DFNA5 mRNA. The identity of the DFNA5 RT-PCR
product was confirmed by sequencing.3. Results
3.1. Sequence analysis
We used PROSITE [14] to search SWISS-PROT,
TrEMBL and PDB databases using a consensus sequence
of the CCCH domains of Mcm10 proteins as a PROSITE
entry. Apart from known Mcm10 homologues, we identified
the human DFNA5 protein and its mouse homologue Dfna5h
(Fig. 1). Interestingly, the mutation associated with nonsyn-
dromic hearing impairment results in the premature termina-
tion of the DFNA5 open reading frame, so that the truncated
protein is lacking a region containing the CCCH domain [1].
Iterative PSI-BLAST searches [15] with the CCCH domains
did not detect any significant homologies other than DFNA5,
Dfna5h and members of the Mcm10 family.
To further characterize the DFNA5 proteins, we identi-
fied additional DFNA5 homologues. Screening one million
plaques from a horse skin cDNA library resulted in eight
positive clones. Three of these clones were chimeric, four
contained partial horse DFNA5 mRNA and one contained
the complete horse DFNA5 mRNA (2219 bp; GenBank
accession number AY194290). The horse DFNA5 proteinFig. 3. Heterologous expression of the DFNA5 proteins in fission yeast. (A) Wild-
construct containing mouse Dfna5h—pREP3x-mDFNA5 (DFNA5mouse), or hu
human DFNA5—pREP3x-hDFNA5mut (DFNA5mut) were grown on EMM plates
(P138) transformed with either empty vector pREP3x (wt-pREP) or construct c
grown in EMM media without thiamine to induce expression of the mutant DFN
plates to determine viability. Percentage of relative viability was calculated as (
colonies at t = 18 h since thiamine withdrawal). Values represent averages of two ex
Aliquots for flow cytometry were taken at indicated time since thiamine withdrawa
A taken at indicated time since thiamine withdrawal. Left-hand panels show phas
assays detecting expression of wild-type and mutant alleles of the human DFNA5
with total RNA isolated from the wild-type yeast strain P138 (wt) (lanes 1–2) or t
3–4) or pREP3x-hDFNA5 construct (DFNA5) (lanes 5–10) or pREP3x-DFNA
medium with or without thiamine for 20 h. RT-PCR products obtained after 25 or
under + thiamine conditions (lanes 5,6, 11,22) as the nmt1 promoter is known to
PCR amplification where no reverse transcriptase was added (RT) to exclude D
ladder, Invitrogen) is given in lane 17 (M).showed 75.0% similarity with human and 66.6% similarity
with mouse DFNA5.
Only one partial cDNA clone resulted after screening 106
clones from a rat brain cDNA library (1515 bp; GenBank
accession number AY194291). The rat brain library was
rescreened using a rat-specific DFNA5 probe. In addition,
5V-RACE experiments were performed on the rat brain
library. However, we did not succeed in generating a full-
length rat DFNA5 clone. The partial rat DFNA5 protein
showed 90.7% similarity with mouse, 64.0% with human
and 60.4% with horse DFNA5 (Fig. 2). Both rat and horse
DFNA5 homologues share the domain of homology with
the Mcm10 family (Fig. 1).
Nuclear localization has been shown experimentally for
the human, Xenopus, S. pombe and S. cerevisiae Mcm10
proteins [16]. Subcellular localization of DFNA5 proteins has
not been determined yet, but both human DFNA5 and mouse
Dfna5h as well as horse DFNA5 proteins share a stretch of
positively charged amino acid residues (KKKR) near their N-
termini, which resemble a basic core of the monopartite
nuclear localization signal K(K/R)X(K/R) [17]. Although
PSORT II prediction identified a ‘‘pat4’’ type of nuclear
localization signal in all DFNA5 homologues, it predicted
the cytoplasmic localization of DFNA5 proteins as the most
likely [18]. Therefore, the subcellular localization of DFNA5
proteins will need to be experimentally determined.
3.2. Heterologous expression of DFNA5 genes in yeast
To further characterize DFNA5, we have cloned wild-
type alleles of the mouse Dfna5h and human DFNA5 as well
as the mutant DFNA5 allele from DFNA5 patients and
expressed them in the fission yeast S. pombe under a control
of regulatable nmt1 promoter [19]. The nmt1 promoter can
be repressed in the presence of thiamine in the growth
medium and it can be induced by removing the thiamine.
While heterologous expression of the human and mouse
DFNA5 proteins did not result in any apparent phenotype,
expression of the mutant DFNA5 allele caused loss of
viability of the yeast cells as assessed from growth on plates
lacking thiamine (Fig. 3A). We also observed a reduction intype strain (P138) transformed with either empty vector pREP3x (pREP), or
man wild-type DFNA5—pREP3x-hDFNA5 (DFNA5) or mutant allele of
with or without added thiamine for 3 days at 32 jC. (B) Wild-type strains
ontaining mutant DFNA5 allele—pREP3x-hDFNA5mut (DFNA5mut) were
A5 gene for the indicated time. Aliquots were taken and plated onto YE3S
number of colonies at time = t since thiamine withdrawal)100/(number of
periments. (C) Flow cytometry analysis of the strains described for panel A.
l. (D) Light microscopy images of ethanol-fixed cells as described for panel
e images and right-hand panels show DAPI staining of DNA. (E) RT-PCR
heterologously expressed in the yeast cells. RT-PCR assays were performed
he P138 strain transformed with either empty vector pREP3x (pREP) (lanes
5mut construct (DFNA5mut) (lanes 11–16). Strains were grown in EMM
28 cycles of PCR amplification are shown. RT-PCR products are also seen
be leaky when repressed with thiamine. Control reactions after 28 cycles of
NA contamination in the samples are shown. DNA size marker (1-kb DNA
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medium lacking thiamine (Fig. 3B). Flow cytometry of
exponentially growing wild-type haploid fission yeast cellsFig. 4. Mutant DFNA5 allele heterologously expressed in fission yeast has syntheti
containing temperature-sensitive alleles of cdc23 and transformed with either em
mutant DFNA5 allele—pREP3x-hDFNA5mut (cdc23tstd-DFNA5mut, cdc23-IE2-td
temperature, 25 jC, for 24 h and fixed with ethanol. Left-hand panels show phase
elongated cells (longer than 15 AM) is shown. (B) Flow cytometry analysis of the
M36-td) or construct containing mutant DFNA5 allele—pREP3x-hDFNA5mut (cdc
permissive temperature (25 jC) for 16 h to induce expression of the mutant DFN
temperature (37 jC) to inactivate the Cdc23 protein. Aliquots for flow cytometryshows only peak corresponding to 2C DNA content. This is
because cells enter S phase before cytokinesis is completed.
Flow cytometry analysis showed that yeast cells expressingc phenotype with cdc23 mutant. (A) cdc23-M36-td and cdc23-IE2-td strains
pty vector pREP3x (cdc23-M36-td, cdc23-IE2-td) or construct containing
-DFNA5mut) were grown on EMM with or without thiamine at permissive
images and right-hand panels show DAPI staining of DNA. Percentage of
cdc23-M36-td strain transformed with either empty vector pREP3x (cdc23-
23tstd-DFNA5mut). Strains were grown in EMM media without thiamine at
A5. The cultures were then split and one half was shifted to nonpermissive
were taken at indicated time.
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1C DNA content, suggesting that the cells were blocked in
G1 or early S phase (Fig. 3C). Interestingly, this is the
phenotype associated with mcm10 mutants [5,8]. However,
unlike many fission yeast mutants blocked in DNA repli-
cation, cells expressing mutant DFNA5 did not elongate
significantly (less than 5% of cells were elongated) and
arrested cells did not show a ‘‘cut’’ phenotype where
septation and/or cytokinesis occur in the absence of normal
sister chromatid separation (Fig. 3D). We used an RT-PCR
assay to confirm that both the wild-type and the mutant
alleles of human DFNA5 are expressed in the yeast cells
upon induction (Fig. 3E).
3.3. Genetic interactions between DFNA5 and mcm10
Following a possible link between DFNA5 and Mcm10
proteins, we tested the effect of DFNA5 expression in a
fission yeast mcm10 homologue, the cdc23 mutant. Neither
human nor mouse DFNA5 proteins were able to complement
a fission yeast cdc23 mutant (not shown), which is not
surprising since the proteins do not share significant similar-
ity outside of the CCCH domain. When mutant DFNA5 was
expressed in a cdc23 temperature-sensitive degron mutant
strains (cdc23-M36-td, cdc23-IE2-td), even at the permissive
temperature there was a significantly higher number of
elongated cells compared to strains not expressing the mutant
DFNA5 (Fig. 4A). Elongated cells indicate a cell cycle block,
which uncouples growth from cell cycle events (e.g. block in
chromosomal DNA replication). Moreover, when mutant
DFNA5 expression was induced in a cdc23-M36-td mutant
and subsequently shifted to nonpermissive temperature, cells
arrested with unreplicated DNA earlier than strains not
expressing mutant DFNA5 allele (Fig. 4B). Therefore, in
fission yeast, heterologous expression of the mutant DFNA5
allele has a synthetic phenotype with the cdc23.4. Discussion
Here we describe the first model system for studying
molecular effects caused by the mutation in the DFNA5
gene, which was found to be responsible for nonsyndromic
hearing impairment. Comparison of the wild-type and the
mutant DFNA5 alleles heterologously expressed in yeast
allowed us to examine a phenotype associated with a
dominant negative or gain of function effect of the DFNA5
mutant. We provide several lines of evidence suggesting a
possible link between the DFNA5 and Mcm10 proteins.
Firstly, we identified a domain of homology shared between
the Mcm10 family of replication proteins and members of
the DFNA5 family, including the newly described horse and
rat DFNA5 homologues. The function of the CCCH domain
remains obscure, but its importance is underlined by the fact
that it is essential for the function of Mcm10 proteins. In
addition, this domain is absent in the dominant DFNA5mutant resulting in hearing impairment. Secondly, we found
that heterologous expression of the mutant DFNA5 in
fission yeast leads to a block in G1 or early S phase of
the cell cycle with approximately 1C DNA content. Fur-
thermore, expression of the mutant DFNA5 in the yeast
cdc23 mutant has a synthetic growth defect and the arrest
caused by cdc23 inactivation is faster when the mutant
DFNA5 is induced. The observed effect could be either
direct or indirect and it is possible that there are other
currently unidentified cellular processes affected by the
mutant DFNA5 allele.
Could DFNA5 have a function related to the DNA
replication function of Mcm10? This cannot be strongly
predicted since the proteins do not share significant simi-
larity outside of the CCCH domain and it is unlikely that
DFNA5 is a distant homologue of Mcm10 proteins. How-
ever, it is of interest that the reduction in DFNA5 expression
can contribute to the etoposide resistance in human mela-
noma cells. The etoposide-resistant phenotype may be due
to an increased cellular susceptibility to drug-induced apo-
ptosis [3]. Etoposide is used as an antineoplastic agent and
causes DNA strand breakage via inhibition of DNA top-
oisomerase II. This could implicate DFNA5 in some aspect
of the response to DNA damage. Indeed, alterations in DNA
repair proteins have been observed in drug-resistant mela-
noma lines [20,21]. Alternatively, DFNA5 and Mcm10
proteins may have unrelated functions, but share the CCCH
domain to perform an activity unrelated to DNA replication.
Further experiments are required to clarify the function of
DFNA5. Our fission yeast model now provides a tool to
examine the molecular basis underlying the DFNA5 hearing
impairment in human.Acknowledgements
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